drugset / Trial / NCT05368753

Evaluation of Plasma Concentrations of Intravenous Lidocaine and Epidural Ropivacaine When Used in Combination in Major Abdominal Surgery

NCT05368753 ↗

Phase 4 Completed 51 enrolled Centre Hospitalier Universitaire, Amiens
NaSingle-groupOpen-labelTreatment

Summary

Thoracic epidural analgesia (TEA) is the gold standard analgesia of the laparotomy in major abdominal surgery and can be associated with intravenous lidocaine or subtituted by intravenous lidocaine when TEA is contraindicated and in order to reduce the use of the morphinics in the perioperative period. Side effects can be paralytic ileus or nausea and vomiting and delay the enhanced recovery after surgery. Intravenous lidocaine and TEA share several properties like anti hyperalgesia, anti inflammatory effect, intestinal process, anti tumoral effect… which suggests an additive effect of their combination that was not studied yet.

Timeline

Start
2022-03-09
Primary completion
2024-01-28
Completion
2024-10-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous
Subject Ropivacaine Other / unclassified 5 mg Other

Indications

No indication recorded.